Clinical trial
Umbilical Cord Blood Mononuclear Cell Bank in Hong Kong and Treatment of Neonatal Cerebral Ischemia and Anemia - Part IV Clinical Trial
NCT03352310 is registered in ClinicalTrials.gov with Mononuclear Therapeutics Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Umbilical Cord Blood Mononuclear Cell Bank in Hong Kong and Treatment of Neonatal Cerebral Ischemia and Anemia - Part IV Clinical Trial
- Lead sponsor
- Mononuclear Therapeutics Ltd.
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- April 16, 2018
- Completion date
- December 30, 2020
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anemia, neonatal, cerebral ischemia of newborn, hypoxia neonatal, hypoxic-ischemic encephalopathy